DNA Chip Research Inc. (2397.T)

JPY 653.0

(-1.51%)

Market Cap (In JPY)

4.41 Billion

Revenue (In JPY)

490.46 Million

Net Income (In JPY)

-248.29 Million

Avg. Volume

87.1 Thousand

Currency
JPY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
610.0-2100.0
PE
-
EPS
-
Beta Value
0.783
ISIN
JP3548590003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Ryo Matoba Ph.D.
Employee Count
-
Website
https://www.dna-chip.co.jp
Ipo Date
Details
DNA Chip Research Inc. develops DNA microarrays in Japan. The company offers research and development, contract research, and diagnostic support services. It offers Tbone EX Kit for Japanese forensic laboratories in police force and universities. The company also develops EGFR (epidermal growth factor receptor) Liquid gene analysis software, a disease diagnosis program for detecting mutations in the gene encoding EGFR using DNA extracted from plasma samples or cancer tissues and determining drug efficacy of EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer, as well as focuses on developing a gene panel for testing cancers using sequencing technology. The company was incorporated in 1999 and is based in Tokyo, Japan.